← Back to articles

health

Health & Medicine

The FDA has approved a new drug that could extend survival for late-stage pancreatic cancer patients, offering potential hope for a disease with historically poor outcomes.

HIGH confidence neutral tone

Coverage (16521 articles)

The Irish Times · Jul 27, 2026

PCOS Renamed PMOS: A Game-Changing Recognition of Metabolic Disorder

Polycystic ovary syndrome (PCOS) has been renamed polyendocrine metabolic ovarian syndrome (PMOS) after 10+ years of research involving 22,000 people, reflecting that it's a complex hormonal and metabolic disorder affecting 170 million women worldwide, not just a gynecological issue.

← Previous Page 165 of 689 Next →
Contact Us FAQ